
Sophia Genetics appoints chief financial officer
pharmafile | June 25, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Marylin Mermod Schule, Sophia Genetics
Swiss-based Sophia Genetics that deals in data driven medicine has appointed Marylin Mermod Schule to be its chief financial officer.
Mermod Schule was previously a deputy director at Benjamin de Rothschild Bank and takes much experience to the company. She joined there in 2006 and held several key roles in corporate finance and private equity.
“It is a testament to the strength of Sophia Genetics that we have been able to attract such experienced and knowledgeable professionals to join our team,” says Jurgi Camblong, chief executive and co-founder of Sophia Genetics.
“Marylin’s appointment will help us achieve our corporate objectives in a dynamic marketplace, allowing us to take advance of the numerous exciting opportunities that continue to arise.”
Mermod Schule adds: “The growth of precision medicine and increasing public interest in the value of genetic testing mean it’s a great time to come on board. I look forward to being part of the team that brings this important medical breakthrough to a greater number of patients.”






